切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2018, Vol. 14 ›› Issue (04) : 453 -458. doi: 10.3877/cma.j.issn.1673-5250.2018.04.013

所属专题: 文献

论著

GCKR基因rs780094(C>T)多态性与妊娠期糖尿病发病风险的相关性分析
李亚妮1, 肖景华1,(), 吴益青1, 王艳霞1   
  1. 1. 710061 西安,西北妇女儿童医院妇产科
  • 收稿日期:2017-11-21 修回日期:2018-06-17 出版日期:2018-08-01
  • 通信作者: 肖景华

Correlation analysis between GCKR gene rs780094 (C>T) polymorphism and onset risk of gestational diabetes mellitus

Yani Li1, Jinghua Xiao1,(), Yiqing Wu1, Yanxia Wang1   

  1. 1. Department of Obstetrics and Gynecology, Northwest Women and Children′s Hospital, Xi′an 710061, Shaanxi Province, China
  • Received:2017-11-21 Revised:2018-06-17 Published:2018-08-01
  • Corresponding author: Jinghua Xiao
  • About author:
    Corresponding author: Xiao Jinghua, Email:
  • Supported by:
    Shaanxi Society Development Sci-Tech Research Project(2015SF135)
引用本文:

李亚妮, 肖景华, 吴益青, 王艳霞. GCKR基因rs780094(C>T)多态性与妊娠期糖尿病发病风险的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2018, 14(04): 453-458.

Yani Li, Jinghua Xiao, Yiqing Wu, Yanxia Wang. Correlation analysis between GCKR gene rs780094 (C>T) polymorphism and onset risk of gestational diabetes mellitus[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2018, 14(04): 453-458.

目的

探讨葡萄糖激酶调节蛋白(GCKR)基因rs780094(C>T)多态性与妊娠期糖尿病(GDM)发病风险的相关性。

方法

选择2013年2月至2016年7月,于西北妇女儿童医院妇产科就诊的252例孕妇为研究对象。其中127例为GDM孕妇,纳入GDM组;125例为健康孕妇,纳入对照组。收集2组孕妇的相关临床资料及实验室检测结果。GCKR基因rs780094(C>T)多态性基因型频率,采用实时荧光定量PCR法进行检测。采用成组t检验,对2组孕妇人体质量指数(BMI),总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、尿素浓度,以及总蛋白、白蛋白水平进行比较。采用Mann-Whitney U检验,对2组孕妇空腹血糖、75 g口服葡萄糖耐量试验(OGTT) 2 h血糖、三酰甘油、肌酐、尿酸浓度进行比较。采用χ2检验,对2组孕妇的妊娠期高血压疾病发生率、有糖尿病家族史所占比例,以及GCKR基因rs780094(C>T)多态性基因型、等位基因频率进行比较。本研究遵循的程序符合2013年修订的《世界医学协会赫尔辛基宣言》的要求,并与所有孕妇签署临床研究知情同意书。2组孕妇年龄等一般临床资料比较,差异均无统计学意义(P>0.05)。

结果

①与对照组孕妇相比较,GDM组孕妇BMI、妊娠期高血压疾病发生率、有糖尿病家族史所占比例及空腹血糖、75 g OGTT 2 h血糖、三酰甘油、尿酸浓度均显著升高,而总蛋白、白蛋白水平及肌酐、尿素浓度均显著降低,并且差异均有统计学意义(t=-8.087,χ2=7.280、135.428,Z=-2.752、-3.764、-4.657、-2.631,t=5.957、11.810,Z=2.389,t=6.528;P<0.05)。②GDM组和对照组孕妇GCKR基因rs780094(C>T)多态性基因型频率分布,均符合Hardy-Weinberg平衡定律(χ2=0.758、P=0.685, χ2=1.440、P=0.487)。在共显性模型下,GDM组孕妇GCKR基因rs780094(C>T)多态性CC、CT、TT基因型频率分别为50.4%(64/127)、37.8%(48/127)、11.8%(15/127),对照组分别为34.4%(43/125)、54.4%(68/125)、11.2%(14/125),2组比较,差异有统计学意义(χ2=7.589、P=0.022);在显性模型下,GDM组孕妇CC、CT+TT基因型频率分别为50.4%(64/127)、49.6%(63/127),对照组分别为65.6%(82/125)、11.2%(14/125),2组比较,差异亦有统计学意义(χ2=6.956、P=0.010)。对照组T等位基因频率为38.4%(96/250)。

结论

携带GCKR基因rs780094(C>T)多态性C等位基因的孕妇发生GDM的风险升高。因本研究纳入样本量相对较小,GCKR基因rs780094(C>T)多态性与GDM发病风险的相关性,尚需更多大样本、前瞻性随机对照研究结果证实。

Objective

To explore the correlation between GCKR gene rs780094 (C>T) polymorphism and the onset risk of gestational diabetes mellitus (GDM).

Methods

A total of 252 cases of pregnant women who were treated in Northwest Women and Children′s Hospital were selected as research subjects. They were divided into GDM group which included 127 cases of GDM pregnant women, and control group which included 125 cases of healthy pregnant women. The clinical and laboratory data of each group were collected. The genotypes of GCKR gene rs780094 (C>T) polymorphism were detected by PCR with fluorescent probes. Independent-samples t test was used to compare the body mass index (BMI), and concentrations of 1, 5-anhydro-D-glucitol (AG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and urea, and levels of total protein and albumin between two groups. Mann-Whitney U test was used to compare the concentrations of fasting blood glucose, 75 g oral glucose tolerance test (OGTT) 2 h blood glucose, trigalloyl glycerol, creatinine and uric acid between two groups. Chi-square test was used to compared the incidence of hypertensive disorder complicating pregnancy, the proportion of family history of diabetes, and genotype and allele frequencies of GCKR gene rs780094 (C>T) polymorphism between two groups. The study met the requirements of World Medical Association Declaration of Helsinki revised in 2013 and informed consents for clinical research were signed by all the pregnant women. There were no statistical differences between two groups in the aspects of age and other general clinical data (P>0.05).

Results

①Compared with pregnant women in control group, the BMI, incidence of hypertensive disorder complicating pregnancy, the proportion of family history of diabetes, and concentrations of fasting blood glucose, 75 g OGTT 2 h blood glucose, trigalloyl glycerol and uric acid were significantly increased in the GDM group, while levels of total protein and albumin, and concentrations of creatinine and urea were significantly decreased, and all the differences were statistically significant (t=-8.087, χ2=7.280, 135.428; Z=-2.752, -3.764, -4.657, -2.631; t=5.957, 11.810; Z=2.389, t=6.528; all P<0.05). ②The genotypes distributions of GCKR gene rs780094 (C>T) polymorphism of GDM group and control group both were in line with the Hardy-Weinberg equilibrium law (χ2=0.758, P=0.685; χ2=1.440, P=0.487). In codominant model of GCKR gene rs780094 (C>T) polymorphism, genotype frequencies of CC, CT and TT were 50.4% (64/127), 37.8% (48/127), and 11.8% (15/127), respectively in GDM group, and 34.4% (43/125), 54.4% (68/125), and 11.2% (14/125), respectively in control group, and there was statistically significant difference between two group in genotype frequencies of CC, CT and TT (χ2=7.589, P=0.022). In dominant model of GCKR gene rs780094 (C>T) polymorphism, genotype frequencies of CC and CT/TT were 50.4% (64/127) and 49.6% (63/127), respectively in GDM group, and 65.6% (82/125), 11.2% (14/125), respectively in control group, and there was statistically significant difference between two group in genotype frequencies of CC and CT/TT (χ2=6.956, P=0.010). The minor T allele frequency in the control group was 38.4% (96/250).

Conclusions

Pregnant women carriers of C allele GCKR gene rs780094 (C>T) polymorphism are more likely to develop into GDM. Because of the relatively small sample size in this study, the association between the GCKR gene rs780094 (C>T) polymorphism and the risk of GDM needs more large-sample prospective randomized controlled trials to confirm.

表1 2组孕妇相关临床资料及实验室检测结果比较
表2 2组孕妇GCKR基因rs780094(C>T)多态性基因型和等位基因频率比较[例数(%)]
[1]
American Diabetes Association. Standards of medical care in diabetes-2016 abridged for primary care providers[J]. Clin Diabetes, 2016, 34(1): 3-21.
[2]
Lowe WL Jr, Scholtens DM, Sandler V, et al. Genetics of gestational diabetes mellitus and maternal metabolism[J]. Curr Diab Rep, 2016, 16(2): 15-19.
[3]
Stride A, Shields B, Gill-Carey O, et al. Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia[J]. Diabetologia, 2013, 57(1): 54-56.
[4]
Petta S, Miele L, Bugianesi E, et al. Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic fatty liver disease[J]. PLoS One, 2014, 9(2): e87523.
[5]
董全勇,辛永宁,宣世英. 葡萄糖激酶调节蛋白基因多态性与非酒精性脂肪性肝病相关性的研究进展[J/CD]. 中国肝脏病杂志(电子版), 2015, 7(4): 22-25.
[6]
Lin YC, Chang PF, Chang MH, et al. Genetic variants in GCKR and PNPLA3 confer susceptibility to nonalcoholic fatty liver disease in obese individuals[J]. Am J Clin Nutr, 2014, 99(4): 869-874.
[7]
Petit JM, Masson D, Guiu B, et al. GCKR polymorphism influences liver fat content in patients with type 2 diabetes[J]. Acta Diabetol, 2016, 53(2): 237-242.
[8]
López Rodríguez M, Kaminska D, Lappalainen K, et al. Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells[J]. Genome Med, 2017, 9(1): 63-70.
[9]
American Diabetes Association. 2. Classification and diagnosis of diabetes[J]. Diab Care, 2016, 39(Suppl 1): S13-S22.
[10]
Leon M, Moussa H, Longo M, et al. 842: Rate of GDM and pregnancy outcomes in chronic hypertensive pregnancies with and without gestational diabetes mellitus[J]. Am J Obstet Gynecol, 2015, 212(1): S403-S404.
[11]
Mook-Kanamori DO, Selim MM, Takiddin AH, et al. 1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control[J]. J Clin Endocrinol Metab, 2014, 99(3): E479-E483.
[12]
Boritza KC, dos Santos-Weiss IC, da Silva Couto Alves A, et al. 1,5 Anhydroglucitol serum concentration as a biomarker for screening gestational diabetes in early pregnancy[J]. Clin Chem Laborat Med, 2014, 52(8): e179-e181.
[13]
孔方方,赵玲娟,马振军,等. 2 891例妊娠合并糖代谢异常住院分娩患者的围生期结局变化情况分析[J/CD]. 发育医学电子杂志,2013, 1(2): 78-82.
[14]
余凡,廖海明,殷文静,等. 妊娠期糖尿病患者血糖波动与新生儿出生体重、母体及新生儿不良妊娠结局的相关性研究[J/CD]. 中华妇幼临床医学杂志(电子版), 2016, 12(3): 305-311.
[15]
倪明燕. 妊娠期糖尿病早期筛查与治疗对妊娠结局的影响[J/CD]. 中华妇幼临床医学杂志(电子版), 2015, 11(2): 188-191.
[16]
Hishida A, Morita E, Naito M, et al. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study[J]. Endocr J, 2012, 59(7): 589-599.
[17]
Stuebe AM, Wise A, Nguyen T, et al. Maternal genotype and gestational diabetes[J]. Am J Perinatol, 2014, 31(1): 69-76.
[18]
Huopio H, Cederberg H, Vangipurapu J, et al. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes[J]. Eur J Endocrinol, 2013, 169(3): 291-297.
[19]
Anghebem-Oliveira MI, Webber S, Alberton D, et al. The GCKR gene polymorphism rs780094 is a risk factor for gestational diabetes in a Brazilian population[J]. J Clin Laborat Anal, 2017, 31(2): e22035.
[20]
席金瓯. 血清1,5-脱水葡萄糖醇浓度测定在妊娠期糖尿病筛查中的应用[J]. 中国妇幼保健,2011, 26(32): 5075-5076.
[21]
Ling Y, Li X, Gu Q, et al. Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study[J]. BMC Med Genet, 2011, 12(1): 66.
[22]
Qi Q, Wu Y, Li H, et al. Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population[J]. Diabetologia, 2009, 52(5): 834-843.
[23]
Sparsø T, Andersen G, Nielsen T, et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes[J]. Diabetologia, 2008, 51(1): 70-75.
[1] 陈甜甜, 王晓东, 余海燕. 双胎妊娠合并Gitelman综合征孕妇的妊娠结局及文献复习[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 559-568.
[2] 居晓庆, 金蕴洁, 王晓燕. 剖宫产术后瘢痕子宫患者再次妊娠阴道分娩发生子宫破裂的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 575-581.
[3] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[4] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[5] 周梦玲, 薛志伟, 周淑. 妊娠合并子宫肌瘤的孕期变化及其与不良妊娠结局的关系[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 611-615.
[6] 冉晨曦, 沈如飞, 廖明钰, 廖倩, 周玲, 张玉玲, 隆敏. 垂体瘤孕妇的诊治与围分娩期管理[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 487-491.
[7] 陈樱, 陈艳莉. 高龄孕妇心率变异性原因及围产结局分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 295-301.
[8] 冯丹艳, 曹晓辉, 史玉霞. 血清脂联素与胎盘亮氨酸氨肽酶对妊娠期糖尿病患者妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 302-308.
[9] 匡德凤, 李志国, 华绍芳, 薛凤霞. 高脂诱导孕鼠血清及胎盘组织脂肪酸结合蛋白-4及相关脂蛋白水平变化及其意义[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 338-344.
[10] 邬龙海, 黄淼, 龚云辉, 喻云倩. 血清趋化因子在妊娠期糖尿病孕妇中的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 357-362.
[11] 张璐, 杨惠娟, 刘凯波. 2015—2021年北京市辅助生殖技术助孕活产及高龄孕母占比与不良妊娠结局变化趋势[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 46-53.
[12] 沈立平, 龙驭云, 杨月华, 张敏, 许阳, 赵亚丽, 李静, 张昀, 江世文, 孙志明. 不同避孕方式对女性再次受孕的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 107-112.
[13] 刘雪云, 范颖, 姚爱军, 张胜苗, 吕亚妮, 张冰清, 张晓宇, 刘恒. 基于微信小程序的个体化、全程护理干预对孕妇孕期体重及分娩结局的影响[J]. 中华临床医师杂志(电子版), 2023, 17(04): 455-460.
[14] 王晓怡, 洪凡, 陈晴晴, 孙雯. 新型冠状病毒感染疫情高发状态下封闭封控管理区孕产妇的管理方案研究[J]. 中华产科急救电子杂志, 2023, 12(02): 109-112.
[15] 张娟, 纪青, 胡国宏, 谭成, 王双双, 易秀英. CD11b基因rs4597342位点多态性与川崎病的相关性研究[J]. 中华诊断学电子杂志, 2023, 11(02): 92-96.
阅读次数
全文


摘要